Some studies have revealed that clonality and skewing of TCR repertoires from COVID-19 patients by next-generation sequencing were associated with severity of diseases, such as early CD4+ and CD8+ T cell activation and interferon type I and III responses. This evidence concerns the gene CD4 and COVID-19.